Display search results for ** instead (25 products)

Showing 11-20 of 25

USD 500.00

USD 375.00 save 25 %

26 Sep 2016  |  Global

IoT Security: The Impossible Mission

2015 was the year for Internet of Things (IoT) in term of positive perspectives, growth potential, industry impacts, and new revenue sources. Frost & Sullivan revealed that by 2020, the total global market will reach over $200 billion and every household will have at least 10 connected devices. In the coming year, the construction market will emerg...

USD 500.00

USD 375.00 save 25 %

This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.

USD 450.00

USD 337.50 save 25 %

This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.

USD 450.00

USD 337.50 save 25 %

This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.

USD 450.00

USD 337.50 save 25 %

04 Apr 2016  |  Global

Vital Signs - Emerging Trends and Opportunities in Life Sciences, February 2016

Exciting Developments in Generic Drug Pricing, CRISPR Technology, GenomeAsia 100K and Large-scale Next-generation Sequencing Projects, and Medicare Outcomes

This Vital Signs issues discusses generic drug pricing, CRISPR technology, GenomeAsia 100K and large-scale next-generation sequencing projects, and Medicare outcomes target.

USD 450.00

USD 337.50 save 25 %

At the Manufacturing Leadership Council’s special "Manufacturing 4.0 in Action" event in Nuremberg, Germany, last November, a member of the audience raised the very pertinent question of standards in the M4.0 era. What standards around system interoperability and software could manufacturers rely upon as they moved toward greater connectivity bo...

USD 250.00

USD 187.50 save 25 %

This issue of Vital Signs, released on February 4, 2014, discusses Roches collaboration with Foundation Medicine, Novartis potential anti-aging drug, and DNA Electronics; acquisition of nanoMR, Inc.

USD 500.00

USD 375.00 save 25 %

This issue of Vital Signs, released on October 3, 2014, discusses Merck KGaAs acquisition of Sigma-Aldrich, highlights from the 2014 AACC Meeting, Abbotts CE Mark for FreeStyle® Libre, laboratory developed test (LDT) regulations, and the sale of Fortis Healthcares Singapore subsidiary, RadLink-Asia Pte Ltd, and its arm, RadLink Singapore.

USD 450.00

USD 337.50 save 25 %

This issue of Vital Signs, released on September 3, 2014, discusses Thermo Fisher Scientifics divestment of laboratory equipment company Cole-Parmer to GTCR, the increasing use of large animal biotechnology in human health applications, the collaboration of Life Technologies and RainTree Oncology Services, the agreement between Ventana and Quintile...

USD 450.00

USD 337.50 save 25 %

Showing 11-20 of 25